inVentiv, Bell Medical in Strategic Pact

inVentiv Health has entered a strategic alliance with Bell Medical Solutions, one of Japan’s largest CROs, to offer comprehensive global drug development services to Japanese and international clients conducting studies in Japan. 
 
“This alliance provides Bell Medical Solutions with inVentiv’s significant international reach and the ability to participate in larger, global studies,” said inVentiv Health chief executive officer Paul Meister. “For inVentiv, the alliance bolsters our already significant position in Japan to better support our clients who are capitalizing on exciting opportunities for growth.”
   
“Bell is not just a respected CRO, it is also embedded in the Japanese healthcare and drug approval system,” said Ray Hill, president of inVentiv Health Clinical. “It is a crucial time for our clients operating in Japan and we can now provide all the support they need to succeed.”